Emory Parkinson's Disease and Movement Disorders Program

Emory Parkinson's Disease and Movement Disorders Program Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Emory Parkinson's Disease and Movement Disorders Program, Medical and health, 12 Executive Park Drive NE, Atlanta, GA.

Emory University is a leading clinical and basic research center for Parkinson's Disease and other movement disorders including dystonia, essential tremor, Huntington's Disease, and Tourette syndrome.

Community Conversations with Emory Parkinson’s Disease Researchers | WHEN: Saturday, May 6th, 2023 | 9:00 am – 2:00 pmCo...
04/05/2023

Community Conversations with Emory Parkinson’s Disease Researchers | WHEN: Saturday, May 6th, 2023 | 9:00 am – 2:00 pm
Complimentary lunch will be provided. Register today: https://community13.eventbrite.com

Join in a conversation with Emory Parkinson's disease researchers to discuss current research findings and trends for future research.

04/05/2023
Healthy Controls Needed
02/21/2023

Healthy Controls Needed

04/13/2021

There’s no denying how difficult a year 2020 has been for individuals and families alike. But our resolve is to forge ahead; many have adapted to the huge challenges we’ve faced during the pandemic and are finding new ways to live and thrive.
As we look towards the future the faculty and staff wish to express our gratitude. Please join us on Saturday, April 24, 2021
at 5:30 p.m. to recognize the Boone Family’s commitment to advance current and future interventions in Parkinson’s disease.
https://www.engage.emory.edu/s/1705/alumni/index3.aspx?sid=1705&gid=3&pgid=13456&content_id=11613&bledit=1&dids=1464&appealcode=1DPLS

Make plans to join us to celebrate our research success in Parkinson's disease and Movement Disorders. Saturday, April 2...
04/12/2021

Make plans to join us to celebrate our research success in Parkinson's disease and Movement Disorders. Saturday, April 24, 2021 at 6:00 pm.

Join us now! Registration Link: https://zoom.us/webinar/register/WN_SV9CcbuRQjC3ZY9lkiSfAQMeeting ID: 972 5530 4290Pas...
11/05/2020

Join us now! Registration Link: https://zoom.us/webinar/register/WN_SV9CcbuRQjC3ZY9lkiSfAQ
Meeting ID: 972 5530 4290
Passcode: 661475

Alicia Lipscomb, Public Affairs Specialist, Social Security Administration Topic: Social Security COVID - 19 Updates Shirley Thomas, GeorgiaCares Counselor Topic: Medicare, COVID-19 and 2021

Address

12 Executive Park Drive NE
Atlanta, GA
30329

Telephone

+14047127237

Website

Alerts

Be the first to know and let us send you an email when Emory Parkinson's Disease and Movement Disorders Program posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Making Strides in Movement

The Emory Parkinson’s Disease and Movement Disorders Program has long been recognized among the best in the world. Nearly thirty years ago a Eureka moment in one of our labs allowed scientists to begin mapping the brain. This astonishing achievement led to some of our breakthrough surgical procedures including the Palidotomy and Deep Brain Stimulation used in alleviating rigidity and tremors that accompany this group of diseases.

Because of the courage and willingness of thousands of our patients and their families to participate in clinical trials, our research continues to yield groundbreaking results. Just recently, our collaborative work with other Udall Parkinson’s Disease Research identified genes related to Parkinson’s that hold promise for treatment interventions that will slow the progress of this disease.

To keep this momentum going, we increasingly rely on philanthropic support. Why? Because the NIH, the federal government’s leading research institution, invests only $139 million in Parkinson’s research annually. With continued budget cutbacks, we cannot rely on the government or even private enterprise to fund our labs and clinical trials.